The report will be delivered in 2-3 business days.

Respiratory Diseases Drugs Global Market Report 2020-30: Covid 19 Implications and Growth

Starting Price : $ 4000.00 | Pages : 150 | Published : May 2020 | SKU CODE : 8388 | Format :


The respiratory diseases drugs market consists of sales of respiratory diseases drugs and related services by entities (organizations, sole traders and partnerships) that produce drugs to treat respiratory diseases such as asthma, acute bronchitis, emphysema, cystic fibrosis and other diseases. This industry includes establishments that produce anti-asthmatics and COPD drugs to prevent acute attacks caused by respiratory diseases and cough and cold preparations to treat cough and cold.

The global respiratory diseases drugs market is expected to grow from $65 billion in 2019 to $92.6 billion in 2020 at a compound annual growth rate (CAGR) of 42.5%. The respiratory drugs market witnessed significant growth mainly due to the COVID-19 outbreak. The fact that Covid-19 is essentially a respiratory ailment has boosted the market growth.  Drugs such as Albuterol have registered high growth. The market is then expected to stabilize and grow at a CAGR of 4% from 2021 and reach $97.8 billion in 2023.

North America was the largest region in the global respiratory diseases drugs market, accounting for 49% of the market in 2019. Western Europe was the second largest region accounting for 19% of the global respiratory diseases drugs market. Africa was the smallest region in the global respiratory diseases drugs market.

The demand for PSE-containing cold, allergy, and sinus products is growing due to their effectiveness and convenience. PSE is an active ingredient found in various cold, allergy, and sinus drugs that can provide congestion relief.  However, PSE-containing medicines are mostly sold as a prescription drug, as PSE can also be used for the illegal manufacture of methamphetamine, a recreational drug. This has led drug manufacturers to produce tamper-resistant PSE products. For instance, in March 2017, pharmaceutical companies Acura Pharmaceuticals Inc. and MainPointe Pharmaceuticals LLC entered into an agreement, enabling MainPointe Pharmaceuticals LLC to market NEXAFED and NEXAFED Sinus products in the US and Canada. These drugs utilize tamper-resistant PSE formulation to prevent the illicit production of methamphetamine.

The major players in the global respiratory diseases drugs market are GlaxosmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, Johnson & Johnson

The countries covered in the global respiratory diseases drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

The global respiratory diseases drugs market is segmented: 1) By Type: Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others 3) By Route Of Administration: Oral, Parenteral, Others 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    1. Executive Summary

    2. Report Structure

    3. Respiratory Diseases Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Respiratory Diseases Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Respiratory Diseases Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Respiratory Diseases Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Respiratory Diseases Drugs Market Trends And Strategies

    8. Respiratory Diseases Drugs Market Size And Growth

    8.1. Market Size

    8.2. Historic Market Growth, Value ($ Billion)

    8.2.1. Drivers Of The Market

    8.2.2. Restraints On The Market

    8.3. Forecast Market Growth, Value ($ Billion)

    8.3.1. Drivers Of The Market

    8.3.2. Restraints On The Market

    9. Respiratory Diseases Drugs Market Regional Analysis

    9.1. Global Respiratory Diseases Drugs Market, 2019, By Region, Value ($ Billion)

    9.2. Global Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region

    9.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region

    10. Respiratory Diseases Drugs Market Segmentation

    10.1. Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Anti-Asthmatics And COPD Drugs

    Cough And Cold Preparations

    10.2. Global Respiratory Diseases Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    10.3. Global Respiratory Diseases Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Oral

    Parenteral

    Others

    10.4. Global Respiratory Diseases Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Branded Drugs

    Generic Drugs

    10.5. Global Respiratory Diseases Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    11. Respiratory Diseases Drugs Market Metrics

    11.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2015-2023, Global

    11.2. Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2015-2023, Global

    12. Asia-Pacific Respiratory Diseases Drugs Market

    12.1. Asia-Pacific Respiratory Diseases Drugs Market Overview

    12.2. Asia-Pacific, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)

    12.3. Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    12.4. Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    12.5. Asia-Pacific, Respiratory Diseases Drugs Market Metrics

    12.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Asia-Pacific Countries

    12.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Asia-Pacific Countries

    12.6. Asia-Pacific Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis

    12.7.1. China Respiratory Diseases Drugs Market

    12.7.1.1. China Respiratory Diseases Drugs Market Overview

    12.7.1.2. China Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.1.3. China Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.2. Australia Respiratory Diseases Drugs Market

    12.7.2.1. Australia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.2.2. Australia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.3. Hong Kong Respiratory Diseases Drugs Market

    12.7.3.1. Hong Kong Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.4. India Respiratory Diseases Drugs Market

    12.7.4.1. India Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.4.2. India Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.5. Indonesia Respiratory Diseases Drugs Market

    12.7.5.1. Indonesia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.5.2. Indonesia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.6. Japan Respiratory Diseases Drugs Market

    12.7.6.1. Japan Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.6.2. Japan Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.7. Malaysia Respiratory Diseases Drugs Market

    12.7.7.1. Malaysia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.8. New Zealand Respiratory Diseases Drugs Market

    12.7.8.1. New Zealand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.9. Philippines Respiratory Diseases Drugs Market

    12.7.9.1. Philippines Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.10. Singapore Respiratory Diseases Drugs Market

    12.7.10.1. Singapore Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.11. South Korea Respiratory Diseases Drugs Market

    12.7.11.1. South Korea Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.11.2. South Korea Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.12. Thailand Respiratory Diseases Drugs Market

    12.7.12.1. Thailand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.13. Vietnam Respiratory Diseases Drugs Market

    12.7.13.1. Vietnam Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13. Western Europe Respiratory Diseases Drugs Market

    13.1. Western Europe Respiratory Diseases Drugs Market Overview

    13.2. Western Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)

    13.3. Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    13.4. Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    13.5. Western Europe, Respiratory Diseases Drugs Market Metrics

    13.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Western Europe Countries

    13.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Western Europe Countries

    13.6. Western Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7. Western Europe Respiratory Diseases Drugs Market: Country Analysis

    13.7.1. Austria Respiratory Diseases Drugs Market

    13.7.1.1. Austria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.2. Belgium Respiratory Diseases Drugs Market

    13.7.2.1. Belgium Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.3. Denmark Respiratory Diseases Drugs Market

    13.7.3.1. Denmark Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.4. Finland Respiratory Diseases Drugs Market

    13.7.4.1. Finland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.5. France Respiratory Diseases Drugs Market

    13.7.5.1. France Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.5.2. France Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.6. Germany Respiratory Diseases Drugs Market

    13.7.6.1. Germany Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.6.2. Germany Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.7. Ireland Respiratory Diseases Drugs Market

    13.7.7.1. Ireland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.8. Italy Respiratory Diseases Drugs Market

    13.7.8.1. Italy Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.9. Netherlands Respiratory Diseases Drugs Market

    13.7.9.1. Netherlands Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.10. Norway Respiratory Diseases Drugs Market

    13.7.10.1. Norway Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.11. Portugal Respiratory Diseases Drugs Market

    13.7.11.1. Portugal Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.12. Spain Respiratory Diseases Drugs Market

    13.7.12.1. Spain Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.13. Sweden Respiratory Diseases Drugs Market

    13.7.13.1. Sweden Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.14. Switzerland Respiratory Diseases Drugs Market

    13.7.14.1. Switzerland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.15. UK Respiratory Diseases Drugs Market

    13.7.15.1. UK Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.15.2. UK Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14. Eastern Europe Respiratory Diseases Drugs Market

    14.1. Eastern Europe Respiratory Diseases Drugs Market Overview

    14.2. Eastern Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)

    14.3. Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    14.4. Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    14.5. Eastern Europe, Respiratory Diseases Drugs Market Metrics

    14.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Eastern Europe Countries

    14.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Eastern Europe Countries

    14.6. Eastern Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis

    14.7.1. Czech Republic Respiratory Diseases Drugs Market,  

    14.7.1.1. Czech Republic Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.2. Poland Respiratory Diseases Drugs Market

    14.7.2.1. Poland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.3. Romania Respiratory Diseases Drugs Market

    14.7.3.1. Romania Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.4. Russia Respiratory Diseases Drugs Market

    14.7.4.1. Russia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.4.2. Russia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15. North America Respiratory Diseases Drugs Market

    15.1. North America Respiratory Diseases Drugs Market Overview

    15.2. North America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)

    15.3. North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    15.4. North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    15.5. North America, Respiratory Diseases Drugs Market Metrics

    15.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, North America Countries

    15.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, North America Countries

    15.6. North America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7. North America Respiratory Diseases Drugs Market: Country Analysis

    15.7.1. Canada Respiratory Diseases Drugs Market

    15.7.1.1. Canada Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.2. Mexico Respiratory Diseases Drugs Market

    15.7.2.1. Mexico Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.3. USA Respiratory Diseases Drugs Market

    15.7.3.1. USA Respiratory Diseases Drugs Market Overview

    15.7.3.2. USA Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.3.3. USA Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16. South America Respiratory Diseases Drugs Market

    16.1. South America Respiratory Diseases Drugs Market Overview

    16.2. South America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)

    16.3. South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    16.4. South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    16.5. South America, Respiratory Diseases Drugs Market Metrics

    16.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, South America Countries

    16.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, South America Countries

    16.6. South America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7. South America Respiratory Diseases Drugs Market: Country Analysis

    16.7.1. Argentina Respiratory Diseases Drugs Market

    16.7.1.1. Argentina Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.2. Brazil Respiratory Diseases Drugs Market

    16.7.1.1. Brazil Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.2.2. Brazil Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.3. Chile Respiratory Diseases Drugs Market

    16.7.3.1. Chile Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.4. Colombia Respiratory Diseases Drugs Market

    16.7.4.1. Colombia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.5. Peru Respiratory Diseases Drugs Market

    16.7.5.1. Peru Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.6. Venezuela Respiratory Diseases Drugs Market

    16.7.6.1. Venezuela Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17. Middle East Respiratory Diseases Drugs Market

    17.1. Middle East Respiratory Diseases Drugs Market Overview

    17.2. Middle East, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)

    17.3. Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    17.4. Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    17.5. Middle East, Respiratory Diseases Drugs Market Metrics

    17.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Middle East Countries

    17.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Middle East Countries

    17.6. Middle East Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7. Middle East Respiratory Diseases Drugs Market: Country Analysis

    17.7.1. Saudi Arabia Respiratory Diseases Drugs Market

    17.7.1.1. Saudi Arabia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.2. Israel Respiratory Diseases Drugs Market

    17.7.2.1. Israel Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.3. Turkey Respiratory Diseases Drugs Market

    17.7.3.1. Turkey Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.4. UAE Respiratory Diseases Drugs Market

    17.7.4.1. UAE Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18. Africa Respiratory Diseases Drugs Market

    18.1. Africa Respiratory Diseases Drugs Market Overview

    18.2. Africa, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)

    18.3. Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    18.4. Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    18.5. Africa, Respiratory Diseases Drugs Market Metrics

    18.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Africa Countries

    18.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Africa Countries

    18.6. Africa Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7. Africa Respiratory Diseases Drugs Market: Country Analysis

    18.7.1. Egypt Respiratory Diseases Drugs Market

    18.7.1.1. Egypt Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7.2. Nigeria Respiratory Diseases Drugs Market

    18.7.2.1. Nigeria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7.3. South Africa Respiratory Diseases Drugs Market

    18.7.3.1. South Africa Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    19. Respiratory Diseases Drugs Market Competitive Landscape

    19.1. Competitive Market Overview

    19.2. Market Shares

    19.3. Company Profiles

    19.3.1. GlaxosmithKline Plc

    19.3.1.1. Company Overview

    19.3.1.2. Products And Services

    19.3.1.3. Strategy

    19.3.1.4. Financial Performance

    19.3.2. AstraZeneca Plc

    19.3.2.1. Company Overview

    19.3.2.2. Products And Services

    19.3.2.3. Strategy

    19.3.2.4. Financial Performance

    19.3.3. Merck & Co

    19.3.3.1. Company Overview

    19.3.3.2. Products And Services

    19.3.3.3. Strategy

    19.3.3.4. Financial Performance

    19.3.4. Novartis AG

    19.3.4.1. Company Overview

    19.3.4.2. Products And Services

    19.3.4.3. Strategy

    19.3.4.4. Financial Performance

    19.3.5. Johnson & Johnson

    19.3.5.1. Company Overview

    19.3.5.2. Products And Services

    19.3.5.3. Strategy

    19.3.5.4. Financial Performance

    20. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

    21. Market Background: Pharmaceutical Drugs Market

    21.1. Pharmaceutical Drugs Market Characteristics

    21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global

    21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)

    21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region

    21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

    22. Recommendations

    22.1. Global Respiratory Diseases Drugs Market In 2023- Growth Countries

    22.2. Global Respiratory Diseases Drugs Market In 2023- Growth Segments

    22.3. Global Respiratory Diseases Drugs Market In 2023- Growth Strategies

    23. Appendix

    23.1. NAICS Definitions Of Industry Covered In This Report

    23.2. Abbreviations

    23.3. Currencies

    23.4. Research Inquiries

    23.5. The Business Research Company

    24. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Respiratory Diseases Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 4: Global Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 5: Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Global Respiratory Diseases Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Global Respiratory Diseases Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Global Respiratory Diseases Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Global Respiratory Diseases Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • Table 12: Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2015-2023, Global
  • Table 13: Asia-Pacific, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • Table 17: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Asia-Pacific Countries
  • Table 18: Asia-Pacific Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 19: China Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 20: China Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 21: Australia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 22: Australia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 23: Hong Kong Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 24: India Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 25: India Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 26: Indonesia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 27: Indonesia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 28: Japan Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 29: Japan Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 30: Malaysia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 31: New Zealand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 32: Philippines Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 33: Singapore Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 34: South Korea Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 35: Thailand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 36: Vietnam Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 37: Western Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 38: Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 39: Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 40: Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Western Europe Countries
  • Table 41: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Western Europe Countries
  • Table 42: Western Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 43: Austria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 44: Belgium Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 45: Denmark Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 46: Finland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 47: France Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 48: France Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 49: Germany Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 50: Germany Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 51: Ireland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 52: Italy Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 53: Netherlands Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 54: Norway Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 55: Portugal Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 56: Spain Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 57: Sweden Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 58: Switzerland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 59: UK Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 60: UK Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 61: Eastern Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 62: Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 63: Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 64: Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • Table 65: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Eastern Europe Countries
  • Table 66: Eastern Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 67: Czech Republic Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 68: Poland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 69: Romania Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 70: Russia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 71: Russia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 72: North America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 73: North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 74: North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 75: Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, North America Countries
  • Table 76: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, North America Countries
  • Table 77: North America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 78: Canada Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 79: Mexico Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 80: USA Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 81: USA Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 82: South America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 83: South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 84: South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 85: Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, South America Countries
  • Table 86: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, South America Countries
  • Table 87: South America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 88: Argentina Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 89: Brazil Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 90: Brazil Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 91: Chile Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 92: Colombia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 93: Peru Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 94: Venezuela Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 95: Middle East, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 96: Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 97: Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 98: Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Middle East Countries
  • Table 99: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Middle East Countries
  • Table 100: Middle East Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 101: Saudi Arabia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 102: Israel Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 103: Turkey Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 104: UAE Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 105: Africa, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 106: Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 107: Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 108: Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Africa Countries
  • Table 109: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Africa Countries
  • Table 110: Africa Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 111: Egypt Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 112: Nigeria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 113: South Africa Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 114: GlaxosmithKline Plc Financial Performance
  • Table 115: AstraZeneca Plc Financial Performance
  • Table 116: Merck & Co Financial Performance
  • Table 117: Novartis AG Financial Performance
  • Table 118: Johnson & Johnson Financial Performance
  • Table 119: Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 120: Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 121: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 122: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 123: Global Respiratory Diseases Drugs Market In 2023- Growth Countries
  • Table 124: Global Respiratory Diseases Drugs Market In 2023- Growth Segments
  • Table 125: Global Respiratory Diseases Drugs Market In 2023- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Respiratory Diseases Drugs Market, 2018, By Region, Value ($ Billion)
  • Figure 4: Global Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Figure 5: Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 7: Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • Figure 8: Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2014 - 2022, Global
  • Figure 9: Asia-Pacific, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 10: Asia-Pacific, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 11: Asia-Pacific, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 12: Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • Figure 13: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Asia-Pacific Countries
  • Figure 14: Asia-Pacific Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 15: China Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 16: China Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 17: China Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 18: Australia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 19: Australia Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 20: Australia Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 21: Hong Kong Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 22: India Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 23: India Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 24: India Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 25: Indonesia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 26: Japan Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 27: Japan Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 28: Japan Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 29: Malaysia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 30: New Zealand Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 31: Philippines Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 32: Singapore Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 33: South Korea Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 34: Thailand Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 35: Vietnam Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 36: Western Europe, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 37: Western Europe, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 38: Western Europe, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 39: Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • Figure 40: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Western Europe Countries
  • Figure 41: Western Europe Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 42: Austria Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 43: Belgium Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 44: Denmark Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 45: Finland Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 46: France Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 47: France Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 48: France Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 49: Germany Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 50: Germany Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 51: Germany Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 52: Ireland Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 53: Italy Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 54: Italy Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 55: Italy Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 56: Netherlands Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 57: Norway Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 58: Portugal Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 59: Spain Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 60: Spain Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 61: Spain Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 62: Sweden Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 63: Switzerland Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 64: UK Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 65: UK Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 66: UK Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 67: Eastern Europe, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 68: Eastern Europe, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 69: Eastern Europe, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 70: Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • Figure 71: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Eastern Europe Countries
  • Figure 72: Eastern Europe Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 73: Czech Republic Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 74: Poland Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 75: Romania Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 76: Russia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 77: Russia Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 78: Russia Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 79: North America, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 80: North America, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 81: North America, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 82: Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, North America Countries
  • Figure 83: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, North America Countries
  • Figure 84: North America Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 85: Canada Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 86: Mexico Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 87: USA Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 88: USA Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 89: USA Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 90: South America, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 91: South America, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 92: South America, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 93: Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, South America Countries
  • Figure 94: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, South America Countries
  • Figure 95: South America Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 96: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 97: South America Cough And Cold Preparations Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 98: Argentina Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 99: Brazil Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 100: Brazil Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 101: Brazil Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 102: Chile Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 103: Colombia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 104: Peru Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 105: Venezuela Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 106: Middle East, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 107: Middle East, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 108: Middle East, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 109: Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Middle East Countries
  • Figure 110: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Middle East Countries
  • Figure 111: Middle East Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 112: Saudi Arabia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 113: Israel Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 114: Turkey Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 115: UAE Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 116: Africa, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 117: Africa, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 118: Africa, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 119: Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Africa Countries
  • Figure 120: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Africa Countries
  • Figure 121: Africa Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 122: Egypt Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 123: Nigeria Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 124: South Africa Respiratory Diseases Drugs Market2014 - 2022, Value ($ Billion)
  • Figure 125: GlaxosmithKline Plc Financial Performance
  • Figure 126: AstraZeneca Plc Financial Performance
  • Figure 127: Merck & Co Financial Performance
  • Figure 128: Novartis AG Financial Performance
  • Figure 129: Johnson & Johnson Financial Performance
  • Figure 130: Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022, Growth, By Segment, Value ($ Billion), Global
  • Figure 131: Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • Figure 132: Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Figure 133: Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 134: Global Respiratory Diseases Drugs Market In 2022- Growth Countries
  • Figure 135: Global Respiratory Diseases Drugs Market In 2022- Growth Segments
  • Figure 136: Global Respiratory Diseases Drugs Market In 2022- Growth Strategies
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Ophthalmology Drugs Market By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Personal Care Services Market Report - By Type (Beauty Salons, Spas & Massage, Diet And Weight Reducing Centers, Other Personal Care Services), By End User Location (On Premise, Off Premise), By Age ( Below 15, 15-40, 40-65, Above 65), By Gender (Female, Male) And By Regions | Global Market Opportunities And Strategies To 2030
View Report
Dry Eye Medication Market By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report
Remdesivir Market Global Report 2020-30: COVID 19 Growth and Change
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)